Ersentilide
Alternative Names: CK 3579; HE 93Latest Information Update: 19 Nov 1998
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Developer Bayer HealthCare Pharmaceuticals; Helopharm
- Class Class III antiarrhythmics; Imidazoles; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias